文献速递乳腺骨肌MRCTPET

转移性乳腺癌可持续诊断方法的评估

Evaluation of sustainable diagnostic approaches in metastatic breast cancer (MBC).
PubMed 文献 · Radiol Med · 2025-09-03

本研究回顾性分析70例骨主导型转移性乳腺癌患者,比较WB-MRI、FDG-PET/CT及骨显像联合胸腹盆CT三种治疗监测路径的扫描时间、能耗、温室气体排放、辐射剂量和对比剂用量。WB-MRI生物学暴露最低但能耗和排放最高;FDG-PET/CT能耗和排放中等,重复扫描会显著增加;骨显像联合CT环境影响最低但需多次就诊且对比剂和辐射剂量更高。

要点

  • WB-MRI路径能耗10.36±0.11 kWh/患者、温室气体排放2.53±0.03 kgCO2e,均为最高。
  • FDG-PET/CT路径能耗4.08±0.38 kWh/患者、排放0.99±0.09 kgCO2e,重复扫描会显著增加。
  • 骨显像联合CT路径环境影响最低(7.60±1.07 kWh;1.85±0.26 kgCO2e),但需多次就诊且对比剂和辐射剂量更高。

核心结论

  • WB-MRI为转移性乳腺癌治疗监测提供生物学上更安全的替代方案,但其环境足迹可观;若尽量减少重复扫描,FDG-PET/CT是更可持续的影像选择;整合影像路径和低能耗技术应指导未来诊断策略。

研究设计与样本

  • 回顾性分析70例骨主导型转移性乳腺癌患者,比较WB-MRI(DL1)与FDG-PET/CT(DL2)或骨显像联合胸腹盆CT(DL3)三种诊断路径;能耗按协议定义的活跃期和空闲期计算,生物学暴露从机构RIS-PACS记录评估。

诊断标准与关键数值

  • DL1(WB-MRI)能耗10.36±0.11 kWh/患者,温室气体排放2.53±0.03 kgCO2e。
  • DL2(FDG-PET/CT)能耗4.08±0.38 kWh/患者,温室气体排放0.99±0.09 kgCO2e,重复扫描时显著增加。
  • DL3(骨显像联合CT-CAP)能耗7.60±1.07 kWh,温室气体排放1.85±0.26 kgCO2e,但需多次就诊且对比剂和辐射剂量更高。

临床应用与阅片要点

  • 原文结论认为WB-MRI为转移性乳腺癌治疗监测提供生物学上更安全的替代方案,但环境足迹可观。
  • 原文结论认为若尽量减少重复扫描,FDG-PET/CT是更可持续的影像选择。
  • 原文结论提出整合影像路径和低能耗技术应指导未来诊断策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: Assessing bone metastases in metastatic breast cancer is challenging. Due to rising concerns over energy use and emissions, energy-efficient imaging is essential. This study aimed to compare three diagnostic imaging approaches used in therapy monitoring of MBC patients, evaluating both their environmental impact-quantified by energy consumption and related greenhouse gas emissions-and their biological cost, defined as patient exposure to ionizing radiation and contrast media volume.

METHODS: We retrospectively analysed 70 patients with bone-dominant metastatic breast cancer who underwent WB-MRI (DL1) and either FDG-PET/CT (DL2) or bone scintigraphy (BS) with CT of chest, abdomen, and pelvis (CT-CAP) (DL3). We compared scan time, energy consumption, greenhouse gas emissions (kgCO2e), radiation dose, and contrast media usage across these diagnostic pathways. Energy consumption was calculated using protocol-defined active and idle phases, while biological exposure was assessed from institutional RIS-PACS records.

RESULTS: DL1 had the highest energy consumption (10.36 ± 0.11 kWh/patient) and GHG emissions (2.53 ± 0.03 kgCO2e). DL2 showed moderate energy use (4.08 ± 0.38 kWh/patient) and GHG emissions (0.99 ± 0.09 kgCO2e), which significantly increased with repeat scans. DL3 exhibited the lowest environmental impact (7.60 ± 1.07 kWh; 1.85 ± 0.26 kgCO2e), though required multiple visits and higher contrast media and radiation doses.

CONCLUSION: WB-MRI offers a biologically safer alternative for treatment monitoring in metastatic breast cancer, yet its environmental footprint is substantial. FDG-PET/CT represents a more sustainable imaging option if repeated scans are minimized. Integrated imaging pathways and low-energy technologies should guide future diagnostic strategies.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Masperi A, Girlando CM, Cubadda V, et al. Evaluation of sustainable diagnostic approaches in metastatic breast cancer (MBC). Radiol Med. 2025. PMID: 40900202. doi:10.1007/s11547-025-02082-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。